Department of Pediatrics, Division of Pediatric Infectious Diseases and Immunology; Department of Pediatrics, Division of Pediatric Cardiology; School of Medicine
Immunology and Infectious Disease | Infectious Disease | Pathological Conditions, Signs and Symptoms | Pediatrics | Therapeutics | Virus Diseases
Multisystem inflammatory syndrome in children (MIS-C) associated with COVID-19 is a postinfectious condition identified during the COVID-19 pandemic with specific Centers for Disease Control and Prevention and WHO criteria. Theoretical concerns have been raised whether MIS-C might also occur after COVID-19 vaccination, as the pathogenesis of MIS-C is not yet entirely understood. We present a woman in her late teens who developed MIS-C after having received two doses of Pfizer BioNTech COVID-19 vaccine 12 weeks prior, in the setting of documented anti-spike SARS-CoV-2 IgG positive, antinucleocapsid SARS-CoV-2 IgG negative, and multiple negative surveillance SARS-CoV-2 PCRs done in the 12-week period prior to development of MIS-C. While vaccination remains safe and critical in controlling the pandemic, it may be considered as a potential trigger for MIS-C in patients with no history of infection. Further surveillance is necessary to determine whether MIS-C will emerge as a confirmed adverse event after COVID-19 vaccination.
COVID-19, Pediatrics, Vaccination, Immunization
Rights and Permissions
Copyright © BMJ Publishing Group Limited 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
DOI of Published Version
Wangu Z, Swartz H, Doherty M. Multisystem inflammatory syndrome in children (MIS-C) possibly secondary to COVID-19 mRNA vaccination. BMJ Case Rep. 2022 Mar 30;15(3):e247176. doi: 10.1136/bcr-2021-247176. PMID: 35354564; PMCID: PMC8968554. Link to article on publisher's site
BMJ case reports
Wangu Z, Swartz H, Doherty M. (2022). Multisystem inflammatory syndrome in children (MIS-C) possibly secondary to COVID-19 mRNA vaccination. COVID-19 Publications by UMass Chan Authors. https://doi.org/10.1136/bcr-2021-247176. Retrieved from https://escholarship.umassmed.edu/covid19/390
Creative Commons License
This work is licensed under a Creative Commons Attribution-Noncommercial 4.0 License